These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19637380)

  • 1. TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience.
    Nakase H; Chiba T
    Inflamm Bowel Dis; 2010 Apr; 16(4):550-1. PubMed ID: 19637380
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Pillet S; Jarlot C; Courault M; Del Tedesco E; Chardon R; Saint-Sardos P; Presles E; Phelip JM; Berthelot P; Pozzetto B; Roblin X
    Inflamm Bowel Dis; 2015 Jul; 21(7):1580-6. PubMed ID: 25933392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
    Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
    Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomegalovirus infection in patients with ulcerative colitis].
    Baryshnikov EN; Drozdov VN; Shuliat'ev IS; Parfenov AI; Lazebnik LB
    Eksp Klin Gastroenterol; 2010; (10):25-8. PubMed ID: 21434367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.
    Iida T; Ikeya K; Watanabe F; Abe J; Maruyama Y; Ohata A; Teruyuki S; Sugimoto K; Hanai H
    Inflamm Bowel Dis; 2013 May; 19(6):1156-63. PubMed ID: 23619714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV in moderately active colitis: much ado about nothing?
    Moss AC
    Dig Dis Sci; 2010 Apr; 55(4):880-2. PubMed ID: 20204696
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.
    Campos ST; Portela FA; Tomé L
    Int J Colorectal Dis; 2017 May; 32(5):645-650. PubMed ID: 28084548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    Okahara K; Nagata N; Shimada T; Joya A; Hayashida T; Gatanaga H; Oka S; Sakurai T; Uemura N; Akiyama J
    PLoS One; 2017; 12(9):e0183951. PubMed ID: 28886066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
    Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
    Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
    Fratila OC; Craciun C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
    Pillet S; Pozzetto B; Roblin X
    World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
    Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
    J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis.
    Criscuoli V; Mocciaro F; Orlando A; Rizzuto MR; Renda MC; Cottone M
    Inflamm Bowel Dis; 2009 Jun; 15(6):810-1. PubMed ID: 18839422
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment.
    Sari I; Birlik M; Gonen C; Akar S; Gurel D; Onen F; Akkoc N
    World J Gastroenterol; 2008 May; 14(18):2912-4. PubMed ID: 18473420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive finding of colonic polymerase chain reaction for cytomegalovirus DNA is not false positive but a warning for treating patients with ulcerative colitis refractory to immunosuppressive therapies.
    Nakase H; Yoshino T; Matumura K; Honzawa Y; Yamamoto S; Matsuura M; Chiba T
    Inflamm Bowel Dis; 2011 Feb; 17(2):E13-4. PubMed ID: 20629104
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.
    Delvincourt M; Lopez A; Pillet S; Bourrier A; Seksik P; Cosnes J; Carrat F; Gozlan J; Beaugerie L; Roblin X; Peyrin-Biroulet L; Sokol H
    Aliment Pharmacol Ther; 2014 Apr; 39(7):712-20. PubMed ID: 24506221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on anti-TNF agents in ulcerative colitis.
    Samaan MA; Bagi P; Vande Casteele N; D'Haens GR; Levesque BG
    Gastroenterol Clin North Am; 2014 Sep; 43(3):479-94. PubMed ID: 25110254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
    Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
    J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.